J. M.Patel Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.71 M
- Revenue Growth 10.26%
- Profit Growth 98.50%
- Ebitda 234.81%
- Net Worth 3.30%
- Total Assets 3.66%
About J. M.Patel Life Sciences
J. M.Patel Life Sciences Private Limited (JMLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2003 and has a history of 21 years and six months. Its registered office is in Na, Gujarat.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.71 M.
Jignesh Patel, Jayantibhai Patel, Amita Patel, and One other member serve as directors at the Company.
Company Details
- Location Na, Gujarat
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110GJ2003PTC042708
- Company No.
042708
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at J. M.Patel Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samarth Patel  | Director | 26-Oct-2019 | Current |
| Jignesh Patel | Director | 01-Aug-2003 | Current |
| Jayantibhai Patel | Director | 01-Aug-2003 | Current |
| Amita Patel | Director | 01-Aug-2003 | Current |
Financial Performance of J. M.Patel Life Sciences.
J. M.Patel Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.26% increase. The company also saw a substantial improvement in profitability, with a 98.5% increase in profit. The company's net worth moved up by a moderate rise of 3.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J. M.Patel Life Sciences?
In 2020, J. M.Patel Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.71 M
₹0
Charges Breakdown by Lending Institutions
- The Surat People'S Co-Op. Bank Ltd : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2011 | The Surat People's Co-Op. Bank Ltd | ₹0.94 M | Open |
| 28 Sep 2010 | The Surat People's Co-Op. Bank Ltd | ₹0.77 M | Open |
How Many Employees Work at J. M.Patel Life Sciences?
Unlock and access historical data on people associated with J. M.Patel Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J. M.Patel Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J. M.Patel Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
